‘Next Ozempic’: A new weight loss drug is on its way, aims to deliver 30% weight loss with fewer side effects

Scientists at Tufts University are developing an experimental drug targeting four hormones—GLP-1, GIP, glucagon, and PYY—to achieve significant weight loss with fewer side effects than current GLP-1 medications. This innovative approach aims to mimic the results of bariatric surgery without the operation, potentially offering a safer and more effective solution for obesity.